Thank you for your interests in Liming Heavy Industry. Please feel free to submit your inquiry information to us. our sales manager will contact with you as soon as possible.
Test solution—Prepare a mixture of 5.0 g of Bismuth Citrate and 100 mL of water, and stir by mechanical means the suspension thus obtained for 2 hours. Pass through filter paper. Pass the filtrate thus obtained through a filter having a 0.1-µm or finer porosity. To
.Bismuth Citrate nitric acid, swirl to dissolve, dilute with water to volume, and mix. Transfer 1.0 mL of this solution to a 500-mL volumetric flask, add 250 mL of 1.5 N nitric acid, dilute with water to volume, and mix. This solution contains 2.0 µg of bismuth (Bi)
Bismuth Citrate USP Grade BiC6H5O7 398.08 — 813-93-4. Bismuth Citrate contains not less than 49 percent and not more than 54 percent of bismuth (Bi). Identification: A: Infrared Absorption 197K : on the undried specimen. B: When strongly heated, the salt chars, and on ignition leaves a more or less blackened residue having a yellow surface.
Bismuth Citrate CAS Number 813-93-4, EINECS EC Number 212-390-1, HS Code ---**; Molecular Weight 398.08, Molecular Formula: [O2CCH2C(OH)(CO2)CH2CO2]Bi Specifications of Bismuth Citrate Manufacturers. You are here.
Drug monographs for bismuth provide an overview of the drug product, therapeutic uses, key development issues, regulatory information, and therapeutic classifications on ScriptSave WellRx. Bismuth subsalicylate (BSS) is an oral antidiarrheal agent. It is effective for
Bismuth(III) citrate 1 Product Result Match Criteria: Property, Product Name Synonym Meets ACS Specifications, Meets Reagent Specifications for testing USP/NF monographs GR ACS Supelco pricing Hydrobromic acid 47% Match Criteria: Description
See individual monographs Mechanism of Action As a complex of ranitidine and bismuth citrate, gastric acid secretion is inhibited by histamine-blocking activity at the parietal cell and the structural integrity of H. pylori organisms is disrupted; additionally bismuth reduces the adherence of H. pylori to epithelial cells of the stomach and may exert a cytoprotectant effect, inhibiting pepsin, as well.
1/1/2020 Bismuth is a “green” metal and almost non-toxic to human in comparison with adjacent hypertoxic arsenic (As) and antimony (Sb). 1 The selective toxicity of Bi(III) to H. pylori but not to mammalian cells may arise from the low absorption of bismuth drugs, and interactions with glutathione (GSH) and multidrug resistant transporter-related self-propelled disposal mechanisms in mammalian
Patients with previous uncomplicated ulcer disease currently receiving maintenance antisecretory agents. Determination of Helicobacter pylori status in these patients should be made using blood antibody testing. Patients who are positive for H pylori should be treated with 10 to 14 days of a twice-daily regimen that includes a proton pump inhibitor (PPI) or ranitidine bismuth citrate (RBC
The British Pharmacopoeia The BP makes an important contribution to the role of the Medicines and Healthcare products Regulatory Agency (MHRA) in protecting public health by providing quality standards for UK pharmaceutical substances and medicinal products.
Copyright © 2004-2020 by China Liming Heavy Industry Science and Technology Co. LTD All rights reserved.|sitemap